Avoidant Restrictive Food Intake Disorder (ARFID) is a severe eating disorder that causes people to avoid certain foods or limit their intake. Unlike other eating disorders, ARFID isn’t about body image—it can stem from low appetite, sensory sensitivity to textures and smells, or a fear of choking or vomiting. Affecting around 1–2% of the population, ARFID can lead to malnutrition, health complications, and significant distress.
Our research focuses on understanding ARFID’s causes and how it varies between individuals. We aim to answer big questions: Is ARFID primarily a neurodevelopmental condition, an anxiety disorder, or influenced by physical health issues? Are there distinct subtypes of ARFID requiring different treatments? What are the genetic, environmental, and developmental risk factors for ARFID, and do these differ by subtype?
To explore these questions, we will analyse ALSPAC data, alongside data from the Norwegian MoBa cohort and the Born in Bradford cohort, and work closely with people living with ARFID, healthcare providers, and the eating disorder charity Beat. By involving those with lived experience at every stage, we will ensure our findings are relevant and impactful.
This project will help identify new approaches to diagnosing and treating ARFID, creating evidence-based tools for clinicians and improving support for those affected. With ARFID research in its early stages, this work is crucial to advancing our understanding and shaping better services.
Our goal is to bring real-world benefits to individuals and families struggling with ARFID, ensuring they receive the care and support they need.